Show Summary Details
Page of

Selective serotonin re-uptake inhibitors 

Selective serotonin re-uptake inhibitors
Chapter:
Selective serotonin re-uptake inhibitors
Author(s):

Basant K. Puri

DOI:
10.1093/med/9780199670444.003.0009
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 15 July 2020

The use of SSRIs

Risk of suicide or hostility

Interactions with MAOIs

Withdrawal reactions and dependency

Side-effects of SSRIs

Efficacy

Fluvoxamine

Fluoxetine

Sertraline

Paroxetine

Citalopram

Escitalopram

As implied by their name, the selective serotonin re-uptake inhibitors, commonly abbreviated to SSRIs, selectively inhibit the re-uptake of the neurotransmitter serotonin (also known as 5-hydroxytryptamine or 5-HT for short). The major SSRIs in clinical use are: ...

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.